Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2016 Aug 30;4(11):913–921. doi: 10.1016/S2213-8587(16)30162-0

Appendix Table 1.

Primary and Secondary Outcomes Associated with Percent Weight Change, Stratified by Randomization Group

Weight Change Groups (percent weight loss in first year)

ILI Group Gain /Stable
(<2% loss)
Small Loss
(2 to 5%)
Medium Loss
(5 to 10%)
Large Loss
(≥10%)
Test for
Trend

Primary Outcome
Events / person years 58 / 3096 69 / 3766 114 / 6446 120 / 8257
Crude rate/100 person years 1.87 1.83 1.77 1.45
Unadjusted HR (95% C.I.) REF 0.94 (0.66 – 1.33) 0.91 (0.66 – 1.25) 0.72 (0.52 – 0.99)* 0.03
Adjusted HR ǂ (95% C.I.) REF 0.78(0.54 – 1.13) 0.89 (0.63 – 1.25) 0.61 (0.44 – 0.86)* 0.007

Secondary Outcome
Events / person years 82 / 3018 108 / 3643 151 / 6335 173 / 8127
Crude rate/100 person years 2.72 2.96 2.38 2.13
Unadjusted HR (95% C.I.) REF 1.04 (0.78 – 1.39) 0.84 (0.64 – 1.10) 0.73 (0.56 – 0.96)* 0.003
Adjusted HR ǂ (95% C.I.) REF 0.90 (0.67 – 1.22) 0.79 (0.59 – 1.05) 0.61 (0.45 – 0.80)* <0.0001

Weight Change Groups (percent weight loss in first year)

DSE Group Gain /Stable
(<2% loss)
Small Loss
(2 to 5%)
Medium Loss
(5 to 10%)
Large Loss
(≥10%)
Test for
Trend

Primary Outcome
Events / person years 231 / 13978 72 / 4104 40 / 2124 8 / 685
Crude rate/100 person years 1.65 1.75 1.88 1.17
Unadjusted HR (95% C.I.) REF 1.10 (0.84 – 1.43) 1.16 (0.82 – 1.62) 0.72 (0.35 – 1.45) 0.82
Adjusted HR ǂ (95% C.I.) REF 1.17 (0.89 – 1.54) 1.26 (0.88 – 1.79) 0.71 (0.33 – 1.51) 0.51

Secondary Outcome
Events / person years 340 / 13681 98 / 4014 52 / 2076 13 / 665
Crude rate/100 person years 2.49 2.44 2.50 1.95
Unadjusted HR (95% C.I.) REF 1.02 (0.81 – 1.27) 1.03 (0.77 – 1.38) 0.80 (0.46 – 1.40) 0.76
Adjusted HR ǂ (95% C.I.) REF 1.01 (0.79 – 1.27) 0.99 (0.73 – 1.35) 0.77 (0.42 – 1.42) 0.67
ǂ

adjusted for sex, age, baseline weight(percent weight loss models), baseline fitness (fitness change models),CVD history, insulin use, diabetes duration, smoking status, LDL, SBP, DBP. Primary Outcome: (non-fatal MI, stroke, hospitalized angina, CVD death); Secondary Outcome: (non-fatal MI, stroke, hospitalized angina, CABG/PTCA, hospitalized CHF, carotid endarterectomy, PVD, total mortality)